COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021
Hilda Razzaghi, Mehreen Meghani, Cassandra Pingali, Bradley Crane, Allison L. Naleway, Eric Weintraub, Tat’Yana A. Kenigsberg, Mark J. Lamias, Stephanie A. Irving, Tia L. Kauffman, Kimberly K. Vesco, Matthew F. Daley, Malini B. DeSilva, James G. Donahue, Darios Getahun, Sungching Glenn, Simon J. Hambidge, Lisa A. Jackson, Heather S. Lipkind, Jennifer C. Nelson, Ousseny Zerbo, Titilope Oduyebo, James A. Singleton, Suchita A. Patel
Abstract
and increased availability of vaccine over time. These findings indicate the need for improved outreach to and engagement with pregnant women, especially those from racial and ethnic minority groups who might be at higher risk for severe health outcomes because of COVID-19 (4). In addition, providing accurate and timely information about COVID-19 vaccination to health care providers, pregnant women, and women of reproductive age can improve vaccine confidence and coverage by ensuring optimal shared clinical decision-making.